{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL-6",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00355",
      "entity_text" : "IL-6 receptor",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "One such medication, Sarilumab, is an IL-6 receptor blocker that can be used to decrease the downstream effects of IL-6.",
  "reading_complete" : "2020-08-04T11:08:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:58:07Z",
  "trigger" : "decrease",
  "evidence" : [ "IL-6 receptor blocker that can be used to decrease the downstream effects of IL-6" ],
  "pmc_id" : "6319937",
  "score" : 0
}